Skip to content

A retrospective study on the predictive value of inflammation combined with blood lipid index in the risk of coronary heart disease

A retrospective study on the predictive value of inflammation combined with blood lipid index in the risk of coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033297
Enrollment
Unknown
Registered
2020-05-27
Start date
2020-05-20
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Gold Standard:Clinical outcomes
Index test:A&#32
predictive&#32
model&#32
based&#32
on&#32
combined&#32
with&#32
blood&#32
index&#32
in&#32
the&#32
risk&#32
of&#32

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. CAD group: coronary angiography showed at least one coronary artery or its main branch with diameter stenosis >= 50%, which was definitely diagnosed as coronary atherosclerotic heart disease (CAD); 2. Non CAD group: Patients with no previous history of CAD have no symptoms such as chest pain, chest distress, palpitation or shortness of breath after activity in the near future, and no evidence of CAD has been found through biochemical and ECG tests.

Exclusion criteria

Exclusion criteria: 1. Patients over 80 years old; 2. Pregnant or nursing patients; 3. Patients with acute coronary syndrome, acute heart failure or serious arrhythmia in the past 1 month; 4. Patients with infectious or non infectious inflammation in recent 1 month; 5. Patients with structural heart disease or cardiomyopathy such as valvular heart disease, atrial / ventricular septal defect; 6. Patients with serious hepatorenal insufficiency, thyroid disease, malignant tumor and hematological system disease; 7. Patients who had major surgery or suffered severe trauma in recent 2 months; 8. Patients who have used lipid-lowering drugs, antioxidants, glucocorticoids or non steroidal anti-inflammatory drugs in recent 3 months.

Design outcomes

Primary

MeasureTime frame
inflammatory factors (hsCRP, ESR, MCP-1 and IL-6);lipid profile (HDL-C, TC, TG, apo A1, apo B?Lp(a));SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactYuling Zhang

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

zzhangyuling@126.com+86 13711675897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026